Ameriprise’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $266M | Buy |
4,240,784
+2,112,533
| +99% | +$147M | 0.06% | 311 |
|
|
2025
Q4 | $141M | Buy |
2,128,251
+1,319,537
| +163% | +$85.3M | 0.03% | 463 |
|
|
2025
Q3 | $54.4M | Buy |
808,714
+395,609
| +96% | +$31.3M | 0.01% | 835 |
|
|
2025
Q2 | $36.1M | Sell |
413,105
-266,965
| -39% | -$20.9M | 0.01% | 1031 |
|
|
2025
Q1 | $46.4M | Sell |
680,070
-13,967
| -2% | -$1.14M | 0.01% | 876 |
|
|
2024
Q4 | $54M | Sell |
694,037
-1,590,590
| -70% | -$118M | 0.01% | 799 |
|
|
2024
Q3 | $153M | Sell |
2,284,627
-1,047,691
| -31% | -$86M | 0.04% | 406 |
|
|
2024
Q2 | $378M | Sell |
3,332,318
-554,456
| -14% | -$70.1M | 0.1% | 210 |
|
|
2024
Q1 | $539M | Sell |
3,886,774
-285,243
| -7% | -$35.9M | 0.15% | 156 |
|
|
2023
Q4 | $518M | Buy |
4,172,017
+2,122,184
| +104% | +$217M | 0.16% | 149 |
|
|
2023
Q3 | $191M | Sell |
2,049,833
-206,617
| -9% | -$23.3M | 0.06% | 305 |
|
|
2023
Q2 | $290M | Buy |
2,256,450
+566,591
| +34% | +$68.5M | 0.09% | 228 |
|
|
2023
Q1 | $196M | Buy |
1,689,859
+99,680
| +6% | +$11.2M | 0.06% | 303 |
|
|
2022
Q4 | $180M | Buy |
1,590,179
+790,411
| +99% | +$86.8M | 0.06% | 316 |
|
|
2022
Q3 | $64.5M | Buy |
799,768
+82,206
| +11% | +$6.96M | 0.02% | 606 |
|
|
2022
Q2 | $53.4M | Buy |
717,562
+3,462
| +0.5% | +$316K | 0.02% | 692 |
|
|
2022
Q1 | $91.2M | Buy |
714,100
+419,388
| +142% | +$45.9M | 0.03% | 555 |
|
|
2021
Q4 | $38.9M | Buy |
294,712
+71,152
| +32% | +$10.2M | 0.01% | 963 |
|
|
2021
Q3 | $30.6M | Sell |
223,560
-120,628
| -35% | -$15.2M | 0.01% | 994 |
|
|
2021
Q2 | $36.8M | Sell |
344,188
-96,380
| -22% | -$9.26M | 0.01% | 942 |
|
|
2021
Q1 | $39.8M | Sell |
440,568
-188,888
| -30% | -$17.7M | 0.01% | 878 |
|
|
2020
Q4 | $58.2M | Buy |
629,456
+65,804
| +12% | +$5.88M | 0.02% | 674 |
|
|
2020
Q3 | $58.1M | Buy |
563,652
+87,688
| +18% | +$9.16M | 0.02% | 587 |
|
|
2020
Q2 | $48.2M | Buy |
475,964
+2,100
| +0.4% | +$188K | 0.02% | 638 |
|
|
2020
Q1 | $31.9M | Sell |
473,864
-29,840
| -6% | -$1.86M | 0.02% | 712 |
|
|
2019
Q4 | $27.5M | Buy |
503,704
+55,520
| +12% | +$2.63M | 0.01% | 982 |
|
|
2019
Q3 | $16.7M | Sell |
448,184
-1,856
| -0.4% | -$72.1K | 0.01% | 1278 |
|
|
2019
Q2 | $16.9M | Sell |
450,040
-39,928
| -8% | -$1.26M | 0.01% | 1293 |
|
|
2019
Q1 | $14.3M | Sell |
489,968
-161,952
| -25% | -$5.69M | 0.01% | 1395 |
|
|
2018
Q4 | $19.5M | Buy |
651,920
+150,880
| +30% | +$4.79M | 0.01% | 1070 |
|
|
2018
Q3 | $17.9M | Buy |
501,040
+121,676
| +32% | +$3.77M | 0.01% | 1398 |
|
|
2018
Q2 | $9.01M | Buy |
379,364
+329,324
| +658% | +$6.98M | ﹤0.01% | 1827 |
|
|
2018
Q1 | $928K | Sell |
50,040
-2,860
| -5% | -$42.3K | ﹤0.01% | 3000 |
|
|
2017
Q4 | $759K | Sell |
52,900
-47,332
| -47% | -$615K | ﹤0.01% | 3079 |
|
|
2017
Q3 | $1.09M | Sell |
100,232
-15,693,640
| -99% | -$277M | ﹤0.01% | 2924 |
|
|
2017
Q2 | $289M | Buy |
15,793,872
+2,431,888
| +18% | +$44.9M | 0.14% | 152 |
|
|
2017
Q1 | $283M | Sell |
13,361,984
-1,117,852
| -8% | -$21.8M | 0.15% | 153 |
|
|
2016
Q4 | $216M | Sell |
14,479,836
-34,416
| -0.2% | -$610K | 0.12% | 175 |
|
|
2016
Q3 | $318M | Sell |
14,514,252
-1,381,128
| -9% | -$30.7M | 0.18% | 120 |
|
|
2016
Q2 | $315M | Sell |
15,895,380
-981,792
| -6% | -$16.7M | 0.18% | 118 |
|
|
2016
Q1 | $287M | Sell |
16,877,172
-274,836
| -2% | -$4.59M | 0.17% | 132 |
|
|
2015
Q4 | $351M | Buy |
17,152,008
+1,397,340
| +9% | +$29.1M | 0.21% | 103 |
|
|
2015
Q3 | $338M | Buy |
15,754,668
+13,301,348
| +542% | +$297M | 0.21% | 98 |
|
|
2015
Q2 | $49.1M | Buy |
2,453,320
+852,764
| +53% | +$15M | 0.03% | 531 |
|
|
2015
Q1 | $24.9M | Sell |
1,600,556
-102,500
| -6% | -$1.55M | 0.01% | 865 |
|
|
2014
Q4 | $23.4M | Buy |
1,703,056
+173,164
| +11% | +$2.12M | 0.01% | 873 |
|
|
2014
Q3 | $15.3M | Sell |
1,529,892
-607,024
| -28% | -$6.2M | 0.01% | 1131 |
|
|
2014
Q2 | $21.2M | Buy |
2,136,916
+21,652
| +1% | +$192K | 0.01% | 1001 |
|
|
2014
Q1 | $21.9M | Buy |
2,115,264
+1,055,664
| +100% | +$10.9M | 0.01% | 940 |
|
|
2013
Q4 | $9.38M | Sell |
1,059,600
-7,108
| -0.7% | -$56.3K | 0.01% | 1557 |
|
|
2013
Q3 | $7.53M | Sell |
1,066,708
-177,968
| -14% | -$1.13M | ﹤0.01% | 1657 |
|
|
2013
Q2 | $6.99M | Buy |
+1,244,676
| New | +$5.96M | ﹤0.01% | 1663 |
|
Other funds holding DXCM
VCM
VPM
Ameriprise's DXCM Position: Q1 2026 in Review
Ameriprise increased its DexCom (DXCM) stake by 99% in Q1 2026, buying an estimated $147M and bringing the position to 4,240,784 shares worth $266M. The position accounts for 0.06% of the portfolio, ranked #311.
Ameriprise first reported a position in DXCM in Q2 2013 and has held it in 52 quarters since. The position peaked at $539M in Q1 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Ameriprise held 4,240,784 shares of DexCom worth $266M as of Q1 2026.
- Ameriprise bought 2,112,533 DexCom shares in Q1 2026, an estimated $147M.
- DexCom made up 0.06% of Ameriprise's portfolio in Q1 2026, its #311 holding.
- Ameriprise first reported a position in DexCom in Q2 2013 and has held it in 52 quarters since.
- Ameriprise's DexCom position peaked at $539M in Q1 2024.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.